Week31, 2022
1. Nationwide influenza activity is low, with 0.4% of respiratory specimens testing positive for influenza in clinical labs.
2. Clinical labs report 90.2% of positive specimens as Influenza A and 9.8% as Influenza B.
3. Public health labs report 92.0% of positive specimens as Influenza A (mainly H3N2) and 8.0% as Influenza B; Influenza B subtyping data is limited.
4. Two human infections with the novel Influenza A (H3N2)v virus were reported in West Virginia, linked to swine exposure; no sustained human-to-human transmission was found.
5. Outpatient visits for ILI account for 1.5% of visits nationwide, with higher rates among children aged 0-4 years (6.1%) compared to older age groups.
6. Pneumonia, influenza, or COVID-19 (PIC) accounted for 10.0% of deaths, above the epidemic threshold of 5.5%; most PIC deaths were attributed to COVID-19, with only 4 due to influenza.
7. A total of 506 laboratory-confirmed influenza-related hospitalizations were reported during week 31.
8. No influenza-associated pediatric deaths were reported this week; there were 33 pediatric deaths in total for the 2021-2022 season.
9. Flu vaccination trends were not explicitly highlighted this week, and data interpretation remains impacted by changes in healthcare behavior during the COVID-19 pandemic.
10. Influenza activity is expected to remain low, with unpredictable future patterns due to simultaneous respiratory virus circulation and changing healthcare dynamics.